Generic Name and Formulations:
Lidocaine HCl 3.5%; oph gel; preservative-free.
Indications for AKTEN:
Ocular surface anesthesia during ophthalmologic procedures.
Adults and Children:
For single patient use. 2 drops to the ocular surface in area of planned procedure; may reapply.
Not for injection. Prolonged use may cause corneal opacification and ulceration. Pregnancy (Cat. B). Nursing mothers.
Conjunctival hyperemia, corneal epithelial changes, headache, burning upon instillation.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Oxidized Low-Density Lipoprotein May Predict Risk for Recurrent Stroke
- Inappropriate Prescribing Protocols in Parkinson Disease
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Congress Passes Bill to Fight Opioid Crisis